Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.75 USD | +2.12% | +5.54% | +654.55% |
Apr. 30 | Health Care Flat Amid Mixed Earnings -- Health Care Roundup | DJ |
Apr. 30 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
Financials (USD)
Sales 2024 * | 243M | Sales 2025 * | 274M | Capitalization | 531M |
---|---|---|---|---|---|
Net income 2024 * | -77M | Net income 2025 * | -46M | EV / Sales 2024 * | 2.19 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.94 x |
P/E ratio 2024 * |
-7.23
x | P/E ratio 2025 * |
-13.2
x | Employees | 1,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 70.03% |
Latest transcript on GeneDx Holdings Corp.
1 day | +2.12% | ||
1 week | +6.41% | ||
Current month | +21.56% | ||
1 month | +91.42% | ||
3 months | +432.05% | ||
6 months | +1,311.56% | ||
Current year | +654.55% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 22-04-28 | |
Kevin Feeley
DFI | Director of Finance/CFO | 43 | - |
Paul Kruszka
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Joshua Ruch
BRD | Director/Board Member | 74 | 21-07-21 |
Director/Board Member | 68 | 22-04-30 | |
Keith Meister
BRD | Director/Board Member | 51 | 20-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 20.75 | +2.12% | 967,457 |
24-05-09 | 20.32 | +5.45% | 928,070 |
24-05-08 | 19.27 | -0.10% | 577,611 |
24-05-07 | 19.29 | -1.18% | 486,014 |
24-05-06 | 19.52 | -0.71% | 615,901 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+654.55% | 531M | |
-16.58% | 8.44B | |
+58.90% | 3.96B | |
-39.78% | 2.52B | |
-10.33% | 2.44B | |
-8.91% | 2.22B | |
-2.53% | 1.98B | |
-19.90% | 1.58B | |
-38.30% | 1.3B | |
+2.19% | 1.05B |
- Stock Market
- Equities
- WGS Stock